Detection of systemic and mucosal HPV-specific IgG and IgA antibodies in adolescent girls one and two years after HPV vaccination

Seroprevalence of seven high-risk HPV types in The Netherlands

(2012) Mirte Scherpenisse et al.   VACCINE

Improved Specificity of a Multiplex Immunoassay for Quantitation of Anti-Diphtheria Toxin Antibodies with the Use of Diphtheria Toxoid

(2011) Pieter G. M. van Gageldonk et al.   Clinical and Vaccine Immunology

Correlation between levels of human papillomavirus (HPV)-16 and 18 antibodies in serum and cervicovaginal secretions in girls and women vaccinated with the HPV-16/18 AS04-adjuvanted vaccine

(2011) Tino F. Schwarz et al.   Human vaccines & immunotherapeutics

Female genital tract immunity: distinct immunological challenges for vaccine development

(2011) Rajesh K. Naz   JOURNAL OF REPRODUCTIVE IMMUNOLOGY

A Murine Genital-Challenge Model Is a Sensitive Measure of Protective Antibodies against Human Papillomavirus Infection

(2011) S. Longet et al.   JOURNAL OF VIROLOGY

Overall efficacy of HPV-16/18 AS04-adjuvanted vaccine against grade 3 or greater cervical intraepithelial neoplasia: 4-year end-of-study analysis of the randomised, double-blind PATRICIA trial

(2011) Matti Lehtinen et al.   LANCET ONCOLOGY

Cross-protective efficacy of HPV-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by non-vaccine oncogenic HPV types: 4-year end-of-study analysis of the randomised, double-blind PATRICIA trial

(2011) Cosette M Wheeler et al.   LANCET ONCOLOGY

HPV16/18 L1 VLP vaccine induces cross-neutralizing antibodies that may mediate cross-protection

(2011) Troy J. Kemp et al.   VACCINE

In Vivo Mechanisms of Vaccine-Induced Protection against HPV Infection

(2010) Patricia M. Day et al.   Cell Host & Microbe

Comparison of the immunogenicity and safety ofCervarix™ andGardasil®human papillomavirus (HPV) cervical cancer vaccines in healthy women aged 18–45 years

(2010) Mark H. Einstein et al.   Human vaccines & immunotherapeutics

Long-term persistence of systemic and mucosal immune response to HPV-16/18 AS04-adjuvanted vaccine in preteen/adolescent girls and young women

(2010) Tiina Petäjä et al.   INTERNATIONAL JOURNAL OF CANCER

Natural seroconversion to high-risk human papillomaviruses (hrHPVs) is not protective against related HPV genotypes

(2010) Johanna Palmroth et al.   SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES

Sustained efficacy and immunogenicity of the HPV-16/18 AS04-adjuvanted vaccine up to 7.3 years in young adult women

(2010) N. De Carvalho et al.   VACCINE

Prevalence of human papillomavirus genotypes, and mucosal IgA anti-viral responses in women with cervical ectopy

(2009) Olga L. Monroy et al.   JOURNAL OF CLINICAL VIROLOGY

Factors Associated with Fluctuations in IgA and IgG Levels at the Cervix during the Menstrual Cycle

(2009) Mahboobeh Safaeian et al.   JOURNAL OF INFECTIOUS DISEASES

Safety, immunogenicity, and efficacy of quadrivalent human papillomavirus (types 6, 11, 16, 18) recombinant vaccine in women aged 24–45 years: a randomised, double-blind trial

(2009) Nubia Muñoz et al.   LANCET

Determinants for HPV vaccine uptake in the Netherlands: A multilevel study

(2009) Marc Rondy et al.   VACCINE

Immunobiology of HPV and HPV vaccines

(2008) Margaret Stanley   GYNECOLOGIC ONCOLOGY

A review of cross-protection against oncogenic HPV by an HPV-16/18 AS04-adjuvanted cervical cancer vaccine: Importance of virological and clinical endpoints and implications for mass vaccination in cervical cancer prevention

(2008) David Jenkins   GYNECOLOGIC ONCOLOGY

Immune response to human papillomavirus after prophylactic vaccination with AS04-adjuvanted HPV-16/18 vaccine: Improving upon nature

(2008) Tino F. Schwarz et al.   GYNECOLOGIC ONCOLOGY

Development and validation of a multiplex immunoassay for the simultaneous determination of serum antibodies to Bordetella pertussis, diphtheria and tetanus

(2008) Pieter G.M. van Gageldonk et al.   JOURNAL OF IMMUNOLOGICAL METHODS

Evaluation of systemic and mucosal anti-HPV16 and anti-HPV18 antibody responses from vaccinated women

(2008) Troy J. Kemp et al.   VACCINE